I don’t have live access to pull the very latest headlines right now, but based on recent public updates I see, there are a few notable lines connected to a few individuals named Simon Draper. If you’re looking for the most current news about a specific Simon Draper, please tell me which field or organization he’s associated with (e.g., venture capital, vaccine research, music industry, etc.) or share any extra detail like location or a company name, and I’ll refine the search.
What I can tell you from recent public traces:
- There is ongoing coverage around Simon Draper who has been involved in vaccine-related research and academia, including Oxford-based work and malaria vaccine studies. If you’re after academic updates or publications, I can summarize recent papers or funding announcements tied to him [cite sources from late 2020s/early 2020s].
- In the venture/tech investment space, “Simon Draper” has been associated with individuals who have held leadership or advisory roles at venture firms and startup ecosystems. If your target is business news, I can narrow to corporate moves, board roles, or funding rounds once you specify the domain.
- In music industry circles, there is a well-known Simon Draper linked to Virgin Records in earlier decades; contemporary news may reference historical influence rather than current events, but I can verify whether there are any fresh interviews or retrospectives.
If you can confirm which Simon Draper you mean (field, company, or a rough time frame), I’ll pull the latest verified updates and summarize with sources.
Sources
^“^ The malaria parasite has a protein called RH5, which must bind to a human protein on red blood cells called basigin in order to infect them. In this study, we were able to demonstrate which human antibodies effectively block RH5 from binding with basigin, thus preventing the parasite from spreading through the blood.~”~ Last year Simon Draper presented some of his research into malaria at the Royal Society Summer Exhibition – click here to find out more. You can also find out more about...
lister-institute.org.ukTo date the group has undertaken 22 proof-of-concept Phase 1/2 clinical trials assessing novel vaccine delivery platforms and immunisation regimens; developing controlled human malaria infection (CHMI) models for Plasmodium falciparum and P. vivax; and testing novel blood-stage malaria vaccine antigens (PfRH5 for P. falciparum and PvDBP_RII for P. vivax).
www.ox.ac.ukFounder Venture Builder Board Advisor Investor Building technology that will change the […]
ffnews.comThe Asia New Zealand Foundation Te Whītau Tūhono is New Zealand's leading authority on Asia. We provide experiences and resources to help New Zealanders build their knowledge, skills and confidence to excel in Asia.
www.asianz.org.nzLondon, 6 April 2021: The Company today announces that after fifteen years, Simon Cook will retire from Draper Esprit on 6th April 2021, and will, accordingly, step down as manager of his various portfolio companies and the investment committee of Draper Esprit. Simon founded Draper Esprit in 2006 with Stuart Chapman and was CEO from inception through the IPO in 2016 until the end of 2019. Since then he has acted as Chief Investment Officer and Founding Partner. He resigned from the board of...
www.moltenventures.comFree company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity
find-and-update.company-information.service.gov.ukView Simon Draper's profile in Mesh and automatically generate one for everyone you know.
me.sh